Research shows that people with fatty liver disease have different gut bacteria and blood chemicals than healthy people, with lower levels of a protective bacteria called Dialister invisus. According to Gram Research analysis of 263 participants, blood chemical patterns could identify fatty liver disease with 83 to 93 percent accuracy, and when researchers gave Dialister invisus to mice on unhealthy diets, it reduced weight gain, liver damage, and blood sugar problems. While these findings are promising, more human studies are needed before this bacteria becomes a standard treatment.
Researchers discovered that people with fatty liver disease have different gut bacteria and blood chemicals compared to healthy people, and these differences vary depending on whether they also have high cholesterol or blood sugar problems. According to Gram Research analysis, a specific bacteria called Dialister invisus appears to be protective, and when scientists gave this bacteria to mice on unhealthy diets, it helped reduce weight gain, liver damage, and blood sugar problems. The study suggests that understanding these gut bacteria differences could lead to new treatments for fatty liver disease and related health conditions.
Key Statistics
A 2026 research study of 263 participants found that people with fatty liver disease had significantly lower levels of Dialister invisus bacteria compared to healthy controls, suggesting this bacteria may play a protective role in liver health.
Blood chemical patterns could predict fatty liver disease subgroups with 83 to 93 percent accuracy in a 2026 study of 222 fatty liver disease patients, outperforming gut bacteria analysis alone which achieved only 58 to 73 percent accuracy.
In a 2026 study, mice receiving Dialister invisus supplementation while on high-calorie diets showed reduced body weight, lower liver damage markers, decreased triglycerides, and improved blood sugar control compared to unsupplemented mice.
A 2026 analysis of 222 fatty liver disease patients identified distinct gut bacteria and blood chemical signatures for three disease subgroups, indicating that different types of metabolic problems may require different treatment approaches.
The Quick Take
- What they studied: How gut bacteria and blood chemicals differ between people with fatty liver disease and healthy people, and whether a specific bacteria called Dialister invisus could help treat the condition.
- Who participated: 263 people total: 41 healthy adults and 222 patients with fatty liver disease. Patients were divided into three groups based on whether they had high cholesterol or blood sugar problems.
- Key finding: People with fatty liver disease had lower levels of a protective bacteria called Dialister invisus and higher levels of harmful bacteria. When researchers gave this protective bacteria to mice eating unhealthy diets, it reduced weight gain, liver damage, and blood sugar problems.
- What it means for you: This research suggests that probiotics containing Dialister invisus might someday help treat fatty liver disease, but more human studies are needed before this becomes a standard treatment. If you have fatty liver disease, talk to your doctor about your diet and lifestyle changes, which remain the most proven treatments.
The Research Details
Researchers collected stool samples and blood from 41 healthy people and 222 patients with fatty liver disease. They analyzed the bacteria in the stool using genetic testing and measured chemicals in the blood using advanced laboratory techniques. They divided the fatty liver disease patients into three groups: those with only fatty liver disease, those with fatty liver disease plus high cholesterol, and those with fatty liver disease plus blood sugar problems.
To test whether one specific bacteria could help, the researchers gave Dialister invisus to mice that were fed unhealthy, high-calorie diets. They then measured changes in the mice’s weight, liver health, blood sugar, and cholesterol levels over time.
The researchers used computer programs called classifiers to see if they could predict which group a person belonged to based on their gut bacteria or blood chemicals. This helps show how different these groups really are from each other.
This research approach is important because it looks at multiple pieces of information at once: gut bacteria, blood chemicals, and actual health outcomes in animals. By studying both humans and mice, researchers can see if findings in people might actually work as treatments. The computer prediction models show how reliable these biological markers are for identifying different types of fatty liver disease.
This study has several strengths: it included a reasonably large number of human participants (263 people), used advanced genetic and chemical testing methods, and tested findings in animal models. However, the study is limited because it only looked at one point in time for most participants (not following people over years), and the computer prediction models for gut bacteria alone were only moderately accurate (58 to 73 percent). The mouse experiments are promising but don’t guarantee the same results would happen in humans.
What the Results Show
People with fatty liver disease had significantly different gut bacteria compared to healthy people. The most notable difference was lower levels of Dialister invisus, a bacteria that appears to be protective. They also had higher levels of a harmful bacteria called Phascolarctobacterium_A sp900545025.
When researchers looked at blood chemicals, they found even bigger differences between groups. Blood chemical patterns could predict which group a person belonged to with 83 to 93 percent accuracy, which is much better than gut bacteria alone (58 to 73 percent accuracy). When researchers combined both gut bacteria and blood chemical information together, their predictions were even more accurate, reaching 89 to 96 percent accuracy.
The three subgroups of fatty liver disease patients (those with only fatty liver, those with high cholesterol, and those with blood sugar problems) each had their own unique patterns of bacteria and blood chemicals. This suggests that different types of fatty liver disease may need different treatment approaches.
In the mouse experiments, giving Dialister invisus to mice on unhealthy diets produced impressive results. The mice gained less weight, had lower liver damage markers, lower triglycerides (a type of fat in blood), lower fasting blood sugar, and better glucose tolerance compared to mice that didn’t receive the bacteria.
The study found that fatty liver disease patients had changes in how their gut bacteria produce certain vitamins and nutrients, particularly menaquinone (vitamin K2). This suggests that fatty liver disease may affect not just which bacteria are present, but also what those bacteria do. The different subgroups of fatty liver disease showed distinct patterns in these bacterial functions, indicating that the type of metabolic problems a person has (high cholesterol versus blood sugar problems) shapes their gut bacteria differently.
Previous research has shown that gut bacteria are different in people with fatty liver disease, but this study goes further by showing that the specific pattern of bacteria depends on what other health problems a person has. Earlier studies suggested that certain bacteria might be protective, and this research provides stronger evidence for Dialister invisus specifically. The finding that blood chemicals are better predictors than bacteria alone is somewhat surprising and suggests that measuring blood chemicals might be more useful for diagnosis than measuring bacteria.
This study has several important limitations. First, most of the human data was collected at just one point in time, so researchers couldn’t see how bacteria and blood chemicals change over time or whether changes predict who gets sicker. Second, the study didn’t measure HbA1c or glucose tolerance tests in all patients, which are standard ways to diagnose blood sugar problems, so some patients may have been misclassified. Third, the mouse experiments used only one type of diet and one bacteria strain, so results might not apply to all people or all situations. Finally, this study shows associations (things that go together) but doesn’t prove that the bacteria actually cause the disease or that giving the bacteria will definitely help people.
The Bottom Line
Based on this research, the most reliable current recommendations remain: eat a healthy diet low in processed foods and added sugars, exercise regularly, maintain a healthy weight, and limit alcohol. These proven approaches address fatty liver disease better than any probiotic currently available. Dialister invisus supplementation is promising but not yet ready for human use outside of research studies. If you have fatty liver disease, work with your doctor on lifestyle changes first. Talk to your doctor before starting any new supplements, especially if you take medications.
This research is most relevant for people with fatty liver disease, especially those who also have high cholesterol or blood sugar problems. It’s also important for doctors and researchers working on new treatments for metabolic diseases. People without fatty liver disease don’t need to worry about these findings yet. If you have risk factors for fatty liver disease (obesity, type 2 diabetes, high cholesterol), this research suggests that gut health may be important to monitor.
In the mouse experiments, improvements in weight, liver health, and blood sugar appeared within weeks. However, human bodies work differently and more slowly than mice. If Dialister invisus eventually becomes available as a treatment for people, it would likely take several weeks to months to see meaningful improvements. Lifestyle changes like diet and exercise typically show benefits within 2 to 3 months for fatty liver disease.
Frequently Asked Questions
What is Dialister invisus and can I take it as a probiotic now?
Dialister invisus is a type of gut bacteria that appears to protect against fatty liver disease based on 2026 research. It’s not yet available as a commercial probiotic for humans. Scientists are still studying how it works and whether it’s safe and effective in people, so talk to your doctor before considering any new supplements.
Can probiotics cure fatty liver disease?
Current evidence doesn’t support probiotics as a cure for fatty liver disease. A 2026 study found that Dialister invisus helped mice, but human studies are limited. Diet changes, weight loss, and exercise remain the most proven treatments. Always consult your doctor before starting probiotics, especially if you have liver disease.
How do I know if I have the type of fatty liver disease studied in this research?
This 2026 study looked at three types: fatty liver disease alone, fatty liver disease with high cholesterol, and fatty liver disease with blood sugar problems. Your doctor can diagnose these using blood tests (liver enzymes, cholesterol, fasting glucose) and imaging. Ask your doctor which type you have so you can discuss the most appropriate treatment.
Should I change my diet based on this gut bacteria research?
This 2026 research shows gut bacteria differences in fatty liver disease but doesn’t yet prove specific dietary changes will fix them. Proven dietary approaches include reducing processed foods, added sugars, and alcohol while eating more vegetables and whole grains. Work with your doctor or a dietitian on a personalized plan rather than making changes based solely on this research.
How long would it take to see improvements if I took Dialister invisus?
In the 2026 mouse study, improvements appeared within weeks, but human bodies work differently and more slowly. If this bacteria becomes available for people, realistic improvements would likely take several weeks to months. Lifestyle changes like diet and exercise typically show benefits within 2 to 3 months for fatty liver disease.
Want to Apply This Research?
- Track weekly weight, energy levels, and digestive health (bloating, regularity) if you have fatty liver disease. Also monitor any blood work results your doctor provides, especially liver enzymes (ALT, AST), triglycerides, and fasting blood sugar. This creates a personal record to see if lifestyle changes are working.
- Use the app to set and track daily goals for diet quality (servings of vegetables, whole grains, and lean protein) and exercise (150 minutes per week of moderate activity). Log meals to identify patterns in what triggers bloating or digestive issues, which may relate to your gut bacteria. Set reminders to take any probiotics consistently if your doctor recommends them.
- Create a monthly check-in where you review your weight trend, energy levels, and any digestive symptoms. If your doctor orders blood work, log the results in the app and compare them to previous tests to see if your changes are working. Share this data with your doctor at appointments to guide treatment decisions.
This article summarizes research findings but is not medical advice. Fatty liver disease is a serious condition that requires professional medical evaluation and treatment. Do not start, stop, or change any medications or supplements without talking to your doctor first. The Dialister invisus findings are from animal studies and have not yet been tested in humans. If you have fatty liver disease, high cholesterol, blood sugar problems, or other metabolic conditions, work with your healthcare provider to develop a personalized treatment plan. This research is promising but not yet ready for clinical use in people.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.